Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | CES1 | P23141 | 5/20 | 1.00 |
| ▸ | APAF1 | O14727 | 3/20 | 1.00 |
| ▸ | BCHE | P06276 | 3/20 | 1.00 |
| ▸ | ACHE | P22303 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | CES2 | O00748 | 1/20 | 0.73 |
| ▸ | ALDH3A1 | P30838 | 6/20 | 0.69 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.69 |
| ▸ | ALDH2 | P05091 | 2/20 | 0.69 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30081910 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CES1APAF1BCHEACHE | |
| SCHEMBL5426477 | 1.00 | ALDH1A1 (1.00) | ALDH1A1CES1APAF1BCHEACHE | |
| SCHEMBL18288159 | 0.87 | CES1 (0.90) | ALDH1A1CES1APAF1BCHEACHE | |
| SCHEMBL22177086 | 0.87 | ALDH1A1 (0.78) | ALDH1A1CES1APAF1BCHEACHE | |
| SCHEMBL3027106 | 0.84 | CES1 (1.00) | ALDH1A1CES1APAF1BCHEACHE | |
| SCHEMBL24270334 | 0.84 | APAF1 (0.80) | ALDH1A1CES1APAF1BCHEACHE | |
| SCHEMBL10955382 | 0.84 | ALDH1A1 (0.72) | ALDH1A1CES1APAF1BCHEACHE | |
| SCHEMBL4727488 | 0.84 | ALDH1A1 (0.72) | ALDH1A1CES1APAF1BCHEACHE | |
| SCHEMBL18668985 | 0.83 | ALDH1A1 (0.70) | ALDH1A1CES1APAF1BCHEACHE | |
| SCHEMBL29506660 | 0.82 | ALDH1A1 (1.00) | ALDH1A1CES1APAF1BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014090-A1 | NANOPARTICLES FOR TARGETED NON-SURGICAL SPAYING AND NEUTERING | UNIV GEORGIA (US) | 2026-01-15 | — | — | US | disclosed |
| US-12521354-B2 | Nanoparticles for targeted non-surgical spaying and neutering | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2026-01-13 | — | — | US | disclosed |
| US-20250288532-A1 | NANOPARTICLES FOR TREATING PROSTATE CANCER | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2025-09-18 | — | — | US | disclosed |
| EP-3600254-B1 | CORNEA EPITHELIUM CELL DERIVED VESICLES CONTAINING P53 FOR CANCER THERAPY | EXOPROTHER MEDICAL LTD (IL) | 2025-09-03 | — | — | EP | disclosed |
| US-12350384-B2 | Nanoparticles for treating prostate cancer | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2025-07-08 | — | — | US | disclosed |
| EP-3525791-B1 | USE OF CASPASE-3 INHIBITORS AND CASPASE-3 ACTIVATORS IN THE MANUFACTURE OF MEDICAMENT FOR TREATING CANCER AND WOUND HEALING | TECHNION RES & DEV FOUNDATION (IL) | 2025-05-21 | — | — | EP | disclosed |
| US-20250144038-A1 | NANOPARTICLES FOR PREVENTING PERI/POST-MENOPAUSAL BONE LOSS AND/OR OBESITY | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2025-05-08 | — | — | US | disclosed |
| US-12214085-B2 | Nanoparticles for preventing peri/post-menopausal bone loss and/or obesity | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2025-02-04 | — | — | US | disclosed |
| CN-119302956-A | Application of shikonin combined with octenib in reversing octenib drug-resistant non-small cell lung cancer | 广东医科大学附属医院 | 2025-01-14 | — | — | CN | disclosed |
| CN-119278052-A | Preventing or alleviating adverse reactions associated with T cell cements | 豪夫迈·罗氏有限公司 | 2025-01-07 | — | — | CN | disclosed |
| WO-2022261213-A1 | NANOPARTICLES FOR TARGETED NON-SURGICAL SPAYING AND NEUTERING | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| WO-2022261186-A1 | NANOPARTICLES FOR PREVENTING PERI/POST-MENOPAUSAL BONE LOSS AND/OR OBESITY | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| US-20220387336-A1 | NANOPARTICLES FOR TARGETED NON-SURGICAL SPAYING AND NEUTERING | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2022-12-08 | — | — | US | disclosed |
| US-20220387334-A1 | NANOPARTICLES FOR PREVENTING PERI/POST-MENOPAUSAL BONE LOSS AND/OR OBESITY | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2022-12-08 | — | — | US | disclosed |
| US-20220387335-A1 | NANOPARTICLES FOR TREATING PROSTATE CANCER | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2022-12-08 | — | — | US | disclosed |
| US-20220323406-A1 | METHODS AND COMPOSITIONS FOR DIFFERENTIATING STEM CELLS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-10-13 | — | — | US | disclosed |
| CN-114652851-A | Antibody conjugate of anti-TROP2 protein | 石药集团巨石生物制药有限公司 | 2022-06-24 | — | — | CN | disclosed |
| WO-2022104258-A1 | COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCER PATIENT | AMBAY IMMUNE SENSORS AND CONTROLS, LLC/AMBAY (US) | 2022-05-19 | — | — | WO | disclosed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | disclosed |
| US-11291705-B2 | Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2022-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387335-A1 | NANOPARTICLES FOR TREATING PROSTATE CANCER | FSHR, GNRHR, AR | ALDH1A1 4313/4885CES1 4192/4885APAF1 35/4885 |
| US-20260014090-A1 | NANOPARTICLES FOR TARGETED NON-SURGICAL SPAYING AND NEUTERING | FSHR, GNRHR, LHCGR | ALDH1A1 4648/4885CES1 3399/4885APAF1 44/4885 |
| US-20250144038-A1 | NANOPARTICLES FOR PREVENTING PERI/POST-MENOPAUSAL BONE LOSS AND/OR OBESITY | MORF4L1, POF1B, GNRHR | ALDH1A1 4864/4885CES1 3345/4885APAF1 22/4885 |
| US-20250288532-A1 | NANOPARTICLES FOR TREATING PROSTATE CANCER | FSHR, GNRHR, AR | ALDH1A1 4313/4885CES1 4192/4885APAF1 35/4885 |
| US-20220387336-A1 | NANOPARTICLES FOR TARGETED NON-SURGICAL SPAYING AND NEUTERING | NXF1, POF1B, ASF1A | ALDH1A1 4309/4885CES1 3830/4885APAF1 15/4885 |
| US-12214085-B2 | Nanoparticles for preventing peri/post-menopausal bone loss and/or obesity | MORF4L1, POF1B, GNRHR | ALDH1A1 4864/4885CES1 3345/4885APAF1 22/4885 |
| US-12350384-B2 | Nanoparticles for treating prostate cancer | FSHR, GNRHR, AR | ALDH1A1 4313/4885CES1 4192/4885APAF1 35/4885 |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | ALDH1A1 1582/4885CES1 1127/4885APAF1 2793/4885 |
| US-20220387334-A1 | NANOPARTICLES FOR PREVENTING PERI/POST-MENOPAUSAL BONE LOSS AND/OR OBESITY | MORF4L1, POF1B, GNRHR | ALDH1A1 4864/4885CES1 3345/4885APAF1 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.